News Image

TCBP Trading Continues Unabated on Nasdaq Stock Exchange

Provided By PR Newswire

Last update: Jan 6, 2025

EDINBURGH, Scotland, Jan. 6, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that its American Depository Shares (ADSs) has continued trading on the Nasdaq Global Select Market (Nasdaq) under the ticker symbol 'TCBP'.

Read more at prnewswire.com
Follow ChartMill for more